Literature DB >> 17511794

Association of left ventricular diastolic function abnormalities with aortic elastic properties in asymptomatic patients with type 2 diabetes mellitus. A tissue doppler echocardiographic study.

E Seyfeli1, M Duru, H Saglam, F Akgul, G Kuvandik, H Kaya, F Yalcin.   

Abstract

BACKGROUND: The aim of this study was to investigate the association between the aortic elastic properties and the left ventricular diastolic function measured by tissue Doppler echocardiography (TDE) in asymptomatic type 2 diabetes mellitus.
METHODS: Fifty-seven asymptomatic patients with type 2 diabetes (33 women, mean age: 49 +/- 6 years) and 25 healthy control subjects (19 women, mean age: 46 +/- 7 years) were included in the present study. Diastolic filling indices were measured by conventional (CE) and tissue Doppler echocardiography. The aortic elastic properties [Aortic stiffness index (ASI), aortic distensibility and strain] were measured as previous definition.
RESULTS: Compared with control subjects, the ratio of LV diastolic abnormalities measured by CE and TDE were found higher in patients with type 2 diabetes (36% and 73.6%, p = 0.001, respectively, and 52% and 89.4%, p < 0.001, for septal annulus; 48% and 89.4%, p < 0.001 for septal basal respectively). The ASI was significantly higher (p < 0.001), aortic distensibility and aortic strain were also significantly lower in patients with type 2 diabetes than control subjects (p < 0.001 and p < 0.001 respectively). In the regression analysis, Ao distensibility was correlated to age (beta = -0.299, p = 0.004), septal basal Em/Am ratio (beta =0.543, p < 0.001) and HDL-cholesterol (beta = 0.192, p = 0.039). ASI was also correlated only to age (beta = 0.255, p = 0.044), the presence of diabetes mellitus (beta = 0.304, p = 0.009), mitral A wave (beta = 0.322, p = 0.013) and mitral annulus Em wave (beta = -0.505, p < 0.001).
CONCLUSION: The aortic elastic function is impaired in asymptomatic patients with type 2 diabetes. Increased ASI and decreased Ao distensibility are closely associated with diastolic filling indices measured by CE and TDE.

Entities:  

Mesh:

Year:  2007        PMID: 17511794     DOI: 10.1111/j.1742-1241.2007.01381.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  5 in total

1.  Relationship between left ventricular diastolic function and arterial stiffness in asymptomatic patients with diabetes mellitus.

Authors:  Cornelis J Roos; Dominique Auger; Roxana Djaberi; Eelco J de Koning; Ton J Rabelink; Alberto M Pereira; Jeroen J Bax; Victoria Delgado; J Wouter Jukema; Arthur J Scholte
Journal:  Int J Cardiovasc Imaging       Date:  2012-09-28       Impact factor: 2.357

2.  Serum neutrophil gelatinase-associated lipocalin levels and aortic stiffness in noncritical coronary artery disease.

Authors:  Korhan Soylu; Gökay Nar; Gökhan Aksan; Ömer Gedikli; Sinan İnci; Serkan Yuksel; Rukiye Nar; Ayşegül İdil Soylu; Okan Gulel; Mahmut Şahin
Journal:  Cardiorenal Med       Date:  2014-12       Impact factor: 2.041

3.  Aortic stiffness is related to left ventricular diastolic function in patients with diabetes mellitus type 1: assessment with MRI and speckle tracking strain analysis.

Authors:  Linda D van Schinkel; Dominique Auger; Saskia G C van Elderen; Nina Ajmone Marsan; Victoria Delgado; Hildo J Lamb; Arnold C T Ng; Johannes W A Smit; Jeroen J Bax; Jos J M Westenberg; Albert de Roos
Journal:  Int J Cardiovasc Imaging       Date:  2012-09-22       Impact factor: 2.357

4.  Systolic aortic pressure-time area is a useful index describing arterial wave properties in rats with diabetes.

Authors:  Ru-Wen Chang; Chun-Yi Chang; Ming-Shiou Wu; Hsi-Yu Yu; Jian-Ming Luo; Yih-Sharng Chen; Fang-Yue Lin; Liang-Chuan Lai; Chih-Hsien Wang; Kuo-Chu Chang
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

Review 5.  Diabetic cardiomyopathy: prevalence, determinants and potential treatments.

Authors:  Gaurav S Gulsin; Lavanya Athithan; Gerry P McCann
Journal:  Ther Adv Endocrinol Metab       Date:  2019-03-27       Impact factor: 3.565

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.